Venous Thromboembolism Treatment Market: Key Players, Regional Insights, and Growth Projections

Meticulous Research^®—a leading global market research company, published a research report titled, ‘Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) – Global Forecast to 2030.’
Download Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5745?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=22-08-2024
According to this latest publication from Meticulous Research^®, the global venous thromboembolism treatment market is projected to reach $4.40 billion by 2030, at a CAGR of 7.2%. The high prevalence of venous thromboembolism, rising incidence of cancer, growing prevalence of secondary risk factors such as diabetes and obesity, increase in orthopedic surgical procedures, and the rising demand for minimally invasive treatment procedures are the key factors driving the growth of the venous thromboembolism treatment market. Furthermore, the growing accessibility and affordability of treatment options, advancements in VTE diagnosis and treatment methods, and the market expansion in emerging economies are expected to create market growth opportunities.
However, instances of product failure and product recalls may restrain the market’s growth. Additionally, lack of awareness about venous thromboembolism and increasing awareness of probable side effects of compression garments are major challenges for market growth.
Top 10 companies: https://meticulousblog.org/top-10-companies-in-venous-thromboembolism-treatment-market/?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=22-08-2024
Key Players
The key players profiled in the venous thromboembolism treatment market report are ALN Implants chirurgicaux (ALN Surgical Implants) (France), AngioDynamics, Inc. (U.S.), Argon Medical Devices, Inc. (U.S.), ArjoHuntleigh AB (Sweden), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), DS MAREF Co., LTD (South Korea), Enovis Corporation (U.S.), LifeTech Scientific Corporation (China), Medtronic plc (Ireland), and Stryker Corporation (U.S.).
The global venous thromboembolism treatment market is segmented by device (thrombectomy devices, inferior vena cava filters {retrievable filters and permanent filters}, stockings, compression pumps, and other devices & accessories), application (deep vein thrombosis and pulmonary embolism), end user (hospitals, ambulatory care centers, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the global and regional levels.
Browse in depth: https://www.meticulousresearch.com/product/venous-thromboembolism-treatment-market-5745?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=22-08-2024
Based on application, in 2023, the deep vein thrombosis segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing geriatric population, rising cases of obesity, increasing cases of deep vein thrombosis due to disease-causing lifestyle, excessive alcohol consumption, and the growing awareness and early diagnosis of DVT. Obesity plays a significant role in the development of venous stasis, increasing the susceptibility to DVT. According to the World Health Organization (WHO), in 2021, the global prevalence of obesity exceeded 1 million individuals, encompassing 340 million adolescents, 650 million adults, and 39 million children. This number is expected to increase by about 167 million people, including adults and children, by 2025. Hence, the growing aging population and rising obesity rates are anticipated to drive the demand for devices aimed at preventing deep vein thrombosis during the forecast period
.Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the venous thromboembolism treatment market, followed by Europe.
Quick Buy: https://www.meticulousresearch.com/Checkout/77097308?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=22-08-2024
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Please login to comment on this Post